Reduction of N(ω)-hydroxy-L-arginine by the mitochondrial amidoxime reducing component (mARC).
Kotthaus
Jürke
J
Department of Pharmaceutical and Medicinal Chemistry, Pharmaceutical Institute, Christian-Albrechts-University of Kiel, Germany.
Wahl
Bettina
B
Havemeyer
Antje
A
Kotthaus
Joscha
J
Schade
Dennis
D
Garbe-Schönberg
Dieter
D
Mendel
Ralf
R
Bittner
Florian
F
Clement
Bernd
B
D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives* / Q000378:metabolism; D001550:Benzamidines; D056945:Hep G2 Cells; D006801:Humans; D024101:Mitochondrial Proteins / Q000378:metabolism*; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000378:metabolism*; D013552:Swine
D001550:Benzamidines; D024101:Mitochondrial Proteins; C068309:N(omega)-hydroxyarginine; C053561:benzamidoxime; D001120:Arginine; D010088:Oxidoreductases; C554553:MTARC1 protein, human; C554552:mitochondrial amidoxime reducing component 2, human